8-alk0xy-4-methyl-3 , 4-dihydr0-quinaz0lin-2-YL amines and their use as 5-HT5A receptor ligands

Details for Australian Patent Application No. 2006263925 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Peters, Jens-Uwe; Alanine, Alexander; Luebbers, Thomas; Steward, Lucinda; Gobbi, Luca Claudio; Kolczewski, Sabine

Agent Spruson & Ferguson

Pub. Number AU-A-2006263925

PCT Pub. Number WO2007/000393

Priority 05105699.2 27.06.05 EP

Filing date 16 June 2006

Wipo publication date 4 January 2007

International Classifications

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/000393 Priority application(s): WO2007/000393

3 April 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read 8-alkoxy-4-methyl-3, 4-dihydro-quinazolin-2-yl amines and their use as 5-HT5A receptor ligands

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006263934-Extraction device having a centrifugal separator

2006263924-Chloro-substituted guanidines